ARCHIVES

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

This article is from The Cancer Letter archive.

Vol. 01 No. 49 | December 5, 1975

Download PDF Visit The Full Archive

Related Articles

Presidential Candidates Promise Increases In Funding For Cancer Research, Prevention.

September 14, 2007

House subcommittee proposes 2.8 percent increase for NIH, NCI.

July 16, 2004

Data Presented At Scientific Meetings Can Have Impact On Patient Treatment

March 31, 2006

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

Adjuvant Chemotherapy Unneeded In Children with Low-Risk Disease

March 29, 2013

Five NCAB members complete terms.

February 20, 2004